Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine vs Quetiapine in Overweight/Obese Schizophrenia
NCT00090012Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of olanzapine in schizophrenia and schizoaffective disorder (2 arms), sponsored by Eli Lilly and Company. Primary endpoint: Time to relapse. Started Jul 2004; status: completed.
02
Drugs
olanzapine
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00090012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00090012.